GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe: Athens, Greece Tuesday, December 16, ...
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training: Tuesday, December 16, 2025, 08:00 Hrs [IST] Lalit Kumar Goel, State ...
Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...
The 3rd Edition of Remarkable Women Camaraderie 2026 & Awards, set to take place on February 6, 2026, in Goa, is born from the belief that when women come together, exchange stories, and uplift one ...
World Health Organization launches call for high-level experts to join the Science Council: Geneva Tuesday, December 16, 2025, 09:00 Hrs [IST] The World Health Organization (WHO) ...
India’s lifescience starts-ups see regulatory compliance as a key hurdle for growth: Nandita Vijayasimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] Indian lifescienc ...
IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business: Nandita Vijaysimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] ...
Commerce ministry to facilitate industry connect with regulators on December 17 to boost pharma exports: Shardul Nautiyal, Mumbai Tuesday, December 16, 2025, 08:00 Hrs [IST] In or ...
Panel recommends health ministry to set up industry advisory board: Gireesh Babu, New Delhi Tuesday, December 16, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Health and Famil ...
IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals: Our Bureau, Bengaluru Monday, Dec ...
Greenspace Herbs, the Bengaluru-based company has opened a full-scale US office in New Jersey. The expansion comes as international supplement brands rush to secure a supply of the company's ...
ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...